| Literature DB >> 28982213 |
James Badlani1,2, Ruta Gupta3,4, Deepak Balasubramanian5, Joel Smith1, Peter Luk3, Jonathan Clark1,4.
Abstract
Salivary gland cancers are a complex group of tumours with variations in location, type and grade, all of which influence their biological behaviour. The understanding of salivary gland pathology has evolved at the molecular level in the last decade leading to identification of distinct entities, development of improved methods of diagnosis as well as identifying therapeutic targets for selected high-grade tumours. This article focuses on these advances and their impact on the management of primary salivary gland cancers.Entities:
Keywords: mammary analogue secretory carcinoma; minor salivary glands; mucoepidermoid carcinoma; oral surgery; salivary gland tumours
Mesh:
Substances:
Year: 2017 PMID: 28982213 DOI: 10.1111/ans.14201
Source DB: PubMed Journal: ANZ J Surg ISSN: 1445-1433 Impact factor: 1.872